Drug Patents owned by Aquestive

1. List of Sympazan drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8765167 AQUESTIVE Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
Feb, 2024

(1 year, 14 days from now)

US8603514 AQUESTIVE Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
Apr, 2024

(1 year, 1 month from now)

Drugs and Companies using CLOBAZAM ingredient

Market Authorisation Date: 01 November, 2018

Treatment: NA

Dosage: FILM;ORAL

More Information on Dosage

2. List of Zuplenz drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8580830 AQUESTIVE Non-mucoadhesive film dosage forms
Nov, 2029

(6 years from now)

US9095577 AQUESTIVE Stabilized amine-containing actives in oral film compositions
Jul, 2030

(7 years from now)

Drugs and Companies using ONDANSETRON ingredient

Market Authorisation Date: 02 July, 2010

Treatment: NA

Dosage: FILM;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in